These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17365175)

  • 41. A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathy.
    Maiti B; Arbogast S; Allamand V; Moyle MW; Anderson CB; Richard P; Guicheney P; Ferreiro A; Flanigan KM; Howard MT
    Hum Mutat; 2009 Mar; 30(3):411-6. PubMed ID: 19067361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early onset myopathy with a novel mutation in the Selenoprotein N gene (SEPN1).
    Tajsharghi H; Darin N; Tulinius M; Oldfors A
    Neuromuscul Disord; 2005 Apr; 15(4):299-302. PubMed ID: 15792869
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SEPN1, an endoplasmic reticulum-localized selenoprotein linked to skeletal muscle pathology, counteracts hyperoxidation by means of redox-regulating SERCA2 pump activity.
    Marino M; Stoilova T; Giorgi C; Bachi A; Cattaneo A; Auricchio A; Pinton P; Zito E
    Hum Mol Genet; 2015 Apr; 24(7):1843-55. PubMed ID: 25452428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ryanodine receptor defects in muscle genetic diseases.
    Brini M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1245-55. PubMed ID: 15336972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the Core Formation Process in Congenital Neuromuscular Disease With Uniform Type 1 Fiber and Central Core Disease.
    Ogasawara M; Ogawa M; Nonaka I; Hayashi S; Noguchi S; Nishino I
    J Neuropathol Exp Neurol; 2020 Dec; 79(12):1370-1375. PubMed ID: 33184643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult-onset respiratory insufficiency, scoliosis, and distal joint hyperlaxity in patients with multiminicore disease due to novel Megf10 mutations.
    Liewluck T; Milone M; Tian X; Engel AG; Staff NP; Wong LJ
    Muscle Nerve; 2016 Jun; 53(6):984-8. PubMed ID: 26802438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9-11 November 2002, Naarden, The Netherlands.
    Jungbluth H; Beggs A; Bönnemann C; Bushby K; Ceuterick-de Groote C; Estournet-Mathiaud B; Goemans N; Guicheney P; Lescure A; Lunardi J; Muntoni F; Quinlivan R; Sewry C; Straub V; Treves S; Ferreiro A
    Neuromuscul Disord; 2004 Nov; 14(11):754-66. PubMed ID: 15482962
    [No Abstract]   [Full Text] [Related]  

  • 49. Ryanodine myopathies without central cores--clinical, histopathologic, and genetic description of three cases.
    Rocha J; Taipa R; Melo Pires M; Oliveira J; Santos R; Santos M
    Pediatr Neurol; 2014 Aug; 51(2):275-8. PubMed ID: 24950660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The clinical, histologic, and genotypic spectrum of
    Villar-Quiles RN; von der Hagen M; Métay C; Gonzalez V; Donkervoort S; Bertini E; Castiglioni C; Chaigne D; Colomer J; Cuadrado ML; de Visser M; Desguerre I; Eymard B; Goemans N; Kaindl A; Lagrue E; Lütschg J; Malfatti E; Mayer M; Merlini L; Orlikowski D; Reuner U; Salih MA; Schlotter-Weigel B; Stoetter M; Straub V; Topaloglu H; Urtizberea JA; van der Kooi A; Wilichowski E; Romero NB; Fardeau M; Bönnemann CG; Estournet B; Richard P; Quijano-Roy S; Schara U; Ferreiro A
    Neurology; 2020 Sep; 95(11):e1512-e1527. PubMed ID: 32796131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SEPN1-related myopathy in three patients: novel mutations and diagnostic clues.
    Ardissone A; Bragato C; Blasevich F; Maccagnano E; Salerno F; Gandioli C; Morandi L; Mora M; Moroni I
    Eur J Pediatr; 2016 Aug; 175(8):1113-8. PubMed ID: 26780752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1.
    Dai Y; Liang S; Huang Y; Chen L; Banerjee S
    Oncotarget; 2016 Dec; 7(51):83843-83849. PubMed ID: 27863379
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative RyR1 reduction and loss of calcium sensitivity of RyR1Q1970fsX16+A4329D cause cores and loss of muscle strength.
    Elbaz M; Ruiz A; Bachmann C; Eckhardt J; Pelczar P; Venturi E; Lindsay C; Wilson AD; Alhussni A; Humberstone T; Pietrangelo L; Boncompagni S; Sitsapesan R; Treves S; Zorzato F
    Hum Mol Genet; 2019 Sep; 28(18):2987-2999. PubMed ID: 31044239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of recessive RYR1 mutations in core myopathies.
    Zhou H; Yamaguchi N; Xu L; Wang Y; Sewry C; Jungbluth H; Zorzato F; Bertini E; Muntoni F; Meissner G; Treves S
    Hum Mol Genet; 2006 Sep; 15(18):2791-803. PubMed ID: 16940308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diaphragmatic dysfunction in SEPN1-related myopathy.
    Caggiano S; Khirani S; Dabaj I; Cavassa E; Amaddeo A; Arroyo JO; Desguerre I; Richard P; Cutrera R; Ferreiro A; Estournet B; Quijano-Roy S; Fauroux B
    Neuromuscul Disord; 2017 Aug; 27(8):747-755. PubMed ID: 28606403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
    Zhou H; Lillis S; Loy RE; Ghassemi F; Rose MR; Norwood F; Mills K; Al-Sarraj S; Lane RJ; Feng L; Matthews E; Sewry CA; Abbs S; Buk S; Hanna M; Treves S; Dirksen RT; Meissner G; Muntoni F; Jungbluth H
    Neuromuscul Disord; 2010 Mar; 20(3):166-73. PubMed ID: 20080402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins.
    Hernandez-Lain A; Husson I; Monnier N; Farnoux C; Brochier G; Lacène E; Beuvin M; Viou M; Manéré L; Claeys KG; Fardeau M; Lunardi J; Voit T; Romero NB
    Eur J Med Genet; 2011; 54(1):29-33. PubMed ID: 20888934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RYR1 mutations as a cause of ophthalmoplegia, facial weakness, and malignant hyperthermia.
    Shaaban S; Ramos-Platt L; Gilles FH; Chan WM; Andrews C; De Girolami U; Demer J; Engle EC
    JAMA Ophthalmol; 2013 Dec; 131(12):1532-40. PubMed ID: 24091937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.